Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. PHVS
9. QQQ
10. UNFI

Go back to Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

Mersana (MRSN) PT Raised to $15 at Citi, Opens Catalyst Watch

May 10, 2023 3:24 PM EDT

Citi analyst Ashiq Mubarack raised the price target on Mersana (NASDAQ: MRSN) to $15.00 (from $12.00) while maintaining a Buy rating.

The analys topens a 90-day upside catalyst watch commenting "In mid-2023, MRSN will share topline results from the pivotal UPLIFT Ph2 trial evaluating UpRi in... More